Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Cash & Current Investments (2016 - 2025)

Plus Therapeutics has reported Cash & Current Investments over the past 16 years, most recently at $17.5 million for Q4 2025.

  • Quarterly Cash & Current Investments rose 384.08% to $17.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.5 million through Dec 2025, up 384.08% year-over-year, with the annual reading at $17.5 million for FY2025, 384.08% up from the prior year.
  • Cash & Current Investments was $17.5 million for Q4 2025 at Plus Therapeutics, up from $16.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $21.3 million in Q3 2021 and troughed at $397000.0 in Q1 2024.
  • The 5-year median for Cash & Current Investments is $12.7 million (2023), against an average of $12.7 million.
  • Year-over-year, Cash & Current Investments plummeted 96.88% in 2024 and then skyrocketed 2385.39% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $21.3 million in 2021, then fell by 14.85% to $18.1 million in 2022, then tumbled by 52.79% to $8.6 million in 2023, then crashed by 57.84% to $3.6 million in 2024, then surged by 384.08% to $17.5 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Cash & Current Investments are $17.5 million (Q4 2025), $16.6 million (Q3 2025), and $6.9 million (Q2 2025).